Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1684

1.

Osteoporosis: trials and tribulations.

Seeman E.

Am J Med. 1997 Aug 18;103(2A):74S-87S; discussion 87S-89S. Review.

PMID:
9302899
2.

Aging bone and osteoporosis: strategies for preventing fractures in the elderly.

Ettinger MP.

Arch Intern Med. 2003 Oct 13;163(18):2237-46. Review.

PMID:
14557222
3.
4.

Present and future of osteoporosis therapy.

Seeman E, Tsalamandris C, Bass S, Pearce G.

Bone. 1995 Aug;17(2 Suppl):23S-29S. Review.

PMID:
8579894
5.

Health-economic comparison of three recommended drugs for the treatment of osteoporosis.

Brecht JG, Kruse HP, Möhrke W, Oestreich A, Huppertz E.

Int J Clin Pharmacol Res. 2004;24(1):1-10.

PMID:
15575171
6.

Etidronate and alendronate in the treatment of postmenopausal osteoporosis.

Beauchesne MF, Miller PF.

Ann Pharmacother. 1999 May;33(5):587-99. Review.

PMID:
10369624
7.

Pharmacological treatment of osteoporosis for people over 70.

Moro Alvarez MJ, Díaz-Curiel M.

Aging Clin Exp Res. 2007 Jun;19(3):246-54. Review.

PMID:
17607094
9.

Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention Trial.

Ensrud KE, Black DM, Palermo L, Bauer DC, Barrett-Connor E, Quandt SA, Thompson DE, Karpf DB.

Arch Intern Med. 1997 Dec 8-22;157(22):2617-24.

PMID:
9531231
11.

Comparative efficacy and safety study of etidronate and alendronate in postmenopausal osteoporosis. effect of adding hormone replacement therapy.

Cortet B, Béra-Louville A, Gauthier P, Gauthier A, Marchandise X, Delcambre B.

Joint Bone Spine. 2001 Oct;68(5):410-5.

PMID:
11707007
12.

Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate.

Seibel MJ, Naganathan V, Barton I, Grauer A.

J Bone Miner Res. 2004 Feb;19(2):323-9. Epub 2003 Dec 16.

13.

Strategies for the prevention and treatment of osteoporosis during early postmenopause.

Delaney MF.

Am J Obstet Gynecol. 2006 Feb;194(2 Suppl):S12-23. Review.

PMID:
16448872
14.

Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.

Iwamoto J, Takeda T, Sato Y.

Curr Med Res Opin. 2006 May;22(5):919-28. Review.

PMID:
16709313
15.

Preventing osteoporosis-related fractures: an overview.

Gass M, Dawson-Hughes B.

Am J Med. 2006 Apr;119(4 Suppl 1):S3-S11. Review.

PMID:
16563939
16.

Bisphosphonates for prevention of postmenopausal osteoporosis.

Ravn P.

Dan Med Bull. 2002 Feb;49(1):1-18. Review.

PMID:
11894721
17.

The cost effectiveness of bisphosphonates for the prevention and treatment of osteoporosis: a structured review of the literature.

Fleurence RL, Iglesias CP, Johnson JM.

Pharmacoeconomics. 2007;25(11):913-33. Review.

PMID:
17960951
18.
19.
20.

The antifracture efficacy of alendronate.

Seeman E.

Int J Clin Pract Suppl. 1999 Apr;101:40-5.

PMID:
12675021
Items per page

Supplemental Content

Write to the Help Desk